Drugs / Ledipasvir/sofosbuvir
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02576314 Comparator | May 2015 → Dec 2017 | chronic hepatitis C virus infection | Humanity and Health Research Centre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ledipasvir/sofosbuvir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02576314 ↗ |
| Route | Oral | “administered orally” NCT02576314 ↗ |